CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $20,367,000 | -98.5% | 172 | -98.5% | 0.00% | -100.0% |
| Q4 2020 | $1,397,478,000 | +153132.2% | 11,832 | +118220.0% | 0.00% | – |
| Q1 2019 | $912,000 | +20.2% | 10 | 0.0% | 0.00% | – |
| Q4 2018 | $759,000 | -5.1% | 10 | 0.0% | 0.00% | – |
| Q3 2018 | $800,000 | -100.0% | 10 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $6,358,113,000 | +4.6% | 64,010 | -14.7% | 0.01% | 0.0% |
| Q1 2018 | $6,075,810,000 | +770941.9% | 75,010 | +750000.0% | 0.01% | – |
| Q4 2017 | $788,000 | -14.6% | 10 | 0.0% | 0.00% | – |
| Q3 2017 | $923,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |